Important research news last week saw the release of positive Phase III trial results by Veradermics for its pattern hair loss candidate VDPHL01; Roivant and Priovant for their infectious uveitis drug ...
Zymeworks, the Vancouver-based biotech, has signed an exclusive global license and collaboration agreement with Roche for ...
Danish drugmaker Novo (NOV: N) and US pharma major Eli Lilly (NYSE: LLY) are competing across a widening range of obesity ...
Shares in UCB, the Belgian biopharma company, closed 21.6% higher at 259.10 euros on Thursday after it raised its 2026 ...
The European Commission has approved an indication extension for Johnson & Johnson's Tecvayli (teclistamab) as monotherapy ...
Bolt Biotherapeutics has announced the acquisition of fellow USA-based Prana Therapies, a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies ...
US pharma major AbbVie yesterday announced positive top-line results from the Phase III INTREPID study evaluating the safety ...
US pharma major Merck & Co (NYSE: MRK) and US biotech Moderna (Nasdaq: MRNA) have reported detailed Phase III results showing ...
Pharmaceutical companies’ reliance on Chinese suppliers extends from early laboratory work to the production of medicines for ...
Gilead Sciences revealed it has entered into a definitive agreement to acquire an oral interleukin (IL)-23R inhibitor program ...
Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely ...
Danish clinical-stage techbio Evaxion has announced new three-year immune and clinical outcome data for personalized cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results